Galilee Medical Center
Nahariya, Israel
NCT Number: NCT04970875
Parotidectomy is the treatment of choice for tumors in the parotid gland, with the modified Blair is the most common incision used. In our medical center, the incision is tailored to the size and location of the specific parotid tumor. This retrospective analysis aims to determine the incidence of complications and to assess the relation between the mass and scar characteristics in patients who had undergone parotidectomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Nahariya, Israel
The scar characteristics of patient who had undergone parotidectomy for benign neoplasms at our medical center between 2013 and 2019 will be evaluated. Patients will complete a questionnaire regarding the occurrence of complications.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
QoL questionnaire
Time frame: 1 Year
The Warmald Parotidectomy Complications Questionnaire consists of five items, each addressing a complication common to parotidectomy: numbness of the ear on the operated side, Frey's syndrome, facial depression or deformity, noticeable scar, and pain or discomfort in the scar. Subjects are asked to indicate the extent to which they were disturbed by each of these complications on a scale ranging from 1 (never) to 10 (always).
Western Galilee Hospital-Nahariya
Other Gov
Effect of Parotid Mass Location on Benign Tumor Parotidectomy Scar's Characteristics
Acronym: MiniBlair
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05581979
Adenocarcinoma, Carcinoma
Singapore
View Trial DetailsNCT06034782
Diagnosis, Disease
Thessaloniki, Greece
View Trial DetailsNCT03602079
Adenocarcinoma, Adnexal Diseases
Sarasota, Florida, United States
View Trial DetailsNCT04969835
Adnexal Diseases, Breast Cancer
New York, United States
View Trial Details